In the News

2022

November 17, 2022
Episode 496: Episode 22-47 Ideas, Ideas, Ideas

November 2, 2022
OHSU Second in the Country to Perform Regenerative Brain Cell Therapy Procedure

July 1, 2022
First Patient Dosed in Clinical Trial for a Drug-Resistant Form of Epilepsy

June 30, 2022
Neurona Therapeutics Dosed Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy

June 29, 2022
Upstate doses first patient in national clinical trial of regenerative human cell therapy for treatment of epilepsy

June 1, 2022
The Long Road to Developing a Therapy for Epilepsy

February 24, 2022
Exploring Cell Therapy for the Treatment of Drug-Resistant Epilepsy

2021

November 9, 2021
Promising new approach for people with epilepsy

November 9, 2021
Focal Epilepsy Cell Therapy NRTX-1001 Gets IND Clearance, Set to Begin Phase 1/2 Trial

September 24, 2021
A Mind For Medicine. Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.

June 23, 2021
Neurona Therapeutics is dashing to the clinic with its cell therapy for epilepsy — but first, another venture round

May 19, 2021
Transplanting Specialized Neurons Cory R Nicholas, PhD, Co-Founder and CEO of Neurona Therapeutics, talks to Pharmafile about the world of neurological disorders and transplantation. (This article is taken from Pharmafile Spring 2021, pages 54-55. © Samedan Ltd)

2016-2009

September 22, 2016
Human Neuron Transplants Treat Spinal Cord Injury in Mice

May 4, 2015
The Daily Startup: How This VC Firm is Building Its Own Biotech Companies

December 24, 2014
Stem cells to transplant in the brain: Stealth UCSF spinout Neurona Therapeutics raises $7.6M

May 07, 2013
Successful transplantation of lab-derived interneurons in mice

May 07, 2013
Epileptic mice cured with transplantation of MGE interneurons

June 21, 2012
Reining in pain

September 10, 2009
Progenitor cell therapy for epilepsy